Shanghai Sundise Co.,Ltd. Release: Fuzheng Huayu Composition May Lead to Anti-Liver Fibrosis Treatment in U.S.

SAN FRANCISCO--(BUSINESS WIRE)--At the annual Liver Meeting® of American Association for Study of Liver Diseases on Nov. 6, 2011, Professor Chenghai Liu, director of the Institute of Liver Diseases at Shanghai University of Traditional Chinese Medicine, revealed the botanical preparation Fuzheng Huayu (FZHY) and the newly identified compounds may help reverse liver fibrosis in hepatitis patients.

MORE ON THIS TOPIC